Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-05 HILL MATTHEW C Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +161,200 161,200
2021-12-13 HILL MATTHEW C Chief Financial Officer Purchase +2,500 $9.00 $23K 3,475
2021-12-13 HILL MATTHEW C Chief Financial Officer Purchase +400 $8.90 $4K 3,875
2021-12-13 HILL MATTHEW C Chief Financial Officer Purchase +100 $9.00 $900 3,975
2021-12-13 HILL MATTHEW C Chief Financial Officer Purchase +100 $9.00 $900 4,075
2021-10-19 HILL MATTHEW C Chief Financial Officer Grant or award · Stock Option (Right to Buy) +202,800 202,800

Page 1 of 1 · 6 trades